I often end up buying an odd number of shares as usually I
I often end up buying an odd number of shares as usually I will free up some cash and just purchase exactly how many shares I am able to, which never works out to an even hundred number of shares and often has a non zero last digit. I guess it is unintentional but if at the same time it was messing with the traders that is more than fine with me! They are taking advantage of the low volume, some day the volume will be higher and they won’t be able to play these silly games. Unfortunately in the short term I don’t expect I can free up anymore cash, but was very happy to pick up quite a few shares in the $1.70’s and a pile of warrants in the 0.60’s and even a bunch $0.58. The warrant trading was often very odd given the low volume, I would sometimes hit the ask and get filled below it, or sometimes just get partial fills. When the separation between the bid and ask was big I would aim in the middle and usually get filled if I was patient enough.
Anyway I was fairly content with the number of shares I had when the uplist to NASDAQ occurred but I never imagined a few months later I would have substantially added to my share count, lowered my average cost per share, and accumulated a pile of warrants at an average cost of 71 cents. So I am actually in the green on the warrants by about 8% although there is no way I could sell all of them at the current price as I have as many warrants as a full day’s trading volume. In fact I have more warrants than shares at this point.
I plan on holding my warrants until I can exercise them and then hold those shares for a long time. Although I may have to exercise and sell shares as I could not come up with the money to pay for all the warrants at $3.44, but I will worry about that when the time comes, it is one of those problems that is a nice problem to have! Some math may be required to figure out the right share price point to exercise them at, or if the price of the warrants is good at that point, just sell some. Anyway I haven’t given it much thought and will have to see what happens when the share price goes over $3.44. I have to take into account the amount over $3.44 minus what I paid for each warrant will be taxable income, so depends on how high the share price is when I do exercise them vs how many shares or warrants I would have to sell, and the tax consequences. The math is a little complicated but not too hard, and I will eventually work out the optimum price point.
3
1
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A merger vote rarely makes anyone pound the table, but it does remove one very real way a bank deal can stumble. ODNB Financial Corporation and National Capital Bancorp, Inc. have announced that their shareholders approved the proposed merger. That is meaningful progress, plain and simple. It says the owners who get to live with the outcome have signed off on joining the...
Continue Reading
Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...
Continue Reading
Payroll mistakes are the sort of paper cuts that suddenly turn into a hospital bill for an employer. Würk’s Nov. 19 launch of Bryte AI goes straight at that ugly reality in cannabis, beverage alcohol, and other heavily regulated workplaces, where a bad time entry, missed document, or misunderstood policy can create a far more expensive mess than ordinary office...
Continue Reading
A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...
Continue Reading
A five-hour lab result can matter more than another glossy precision-medicine slogan. MedStar Health says it is using same-day genetic testing for patients with ischemic stroke, giving clinicians information before discharge that previously often arrived more than a week later. That is a practical change, not science-fiction wallpaper: a treatment decision gets made while...
Continue Reading
Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...
Continue Reading
A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...
Continue Reading
Patch Management Finally Gets Some Respect Nothing makes a security buyer flinch faster than a machine carrying a known vulnerability for weeks, and Action1 has plainly found that nerve. The Houston-based autonomous endpoint management company says it was the fastest-growing endpoint management vendor on Deloitte's 2026 Technology Fast 500 for the second consecutive year,...
Continue Reading
July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...
Continue Reading
Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...
Continue Reading
Top 5 Most Recently Viewed Articles
When a major player like A.O. Smith decides to offload a piece of its business, folks tend to sit up and pay attention. This isn't just some run-of-the-mill shuffling. A.O. Smith has inked a deal with CPE to hand over an 81% stake in its China business. What does this transaction bring to the table and who stands to gain? Broken Down for the Curious Investor The numbers...
Continue Reading
NCCN’s Involvement in Global Cancer Initiatives The National Comprehensive Cancer Network is actively participating in a progressive forum uniting various organizations dedicated to cancer control. This gathering includes representatives from approximately 75 nations, marking a significant milestone in international collaboration. Focus of the Cancer Planners Forum The...
Continue Reading
A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...
Continue Reading
Understanding the Current Options Trading Landscape of GE Vernova Recently, financial sectors have shown strong bullish interest in GE Vernova. Our detailed analysis indicates a noteworthy trend in options trading for GE Vernova (GEV), where we've identified an impressive number of unusual trading activities. Digging deeper into the specifics, we observed that 66% of...
Continue Reading
Volatus Aerospace: Leading the Charge in Aerial Innovations Volatus Aerospace Inc. (TSXV: FLT, OTCQX: TAKOF, Frankfurt: ABB) continues to excel as a frontrunner in sovereign aerial solutions. The company recently shared an impressive corporate update, showcasing its robust financial standing, an increasing array of international contracts, and a commitment to align with...
Continue Reading